-
Today15/09/2026
-
Estimated published30/11/2026
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Request for information: External clinical audits of radiation use
HUS Group investigates the solutions and service providers available on the market to arrange external clinical audits of the use of radiation. The subject of the procurement is activities involving the medical exposure class 1 of the HUS Group's use of radiation. The audit must cover the radiation use activities of the HUS hospital area in accordance with the exposure class associated with the audit entity. Clinical audit means an external evaluation meeting the following standards: - Radiation Act 859/2018 - Government Decree on Ionising Radiation 1034/2018 - Decree of the Ministry of Social Affairs and Health on Ionising Radiation 1044/2018 - Radiation and Nuclear Safety Authority Regulations (S series) - Recommendations 1-19 of a clinical expert group under the Ministry of Social Affairs and Health. Clinical audits must be completed by the end of 2028. The scope and content of the audit shall cover the regulatory requirements set out above. To the extent that the audit requires a visit to the functional unit, the audits shall be carried out on weekdays during normal business hours. In addition, the audit should be scheduled in such a way that it interferes with normal clinical practice as little as possible. The audit package comprises the following sub-packages: 1. HUS Diagnostic Centre's angiography activities 2. HUS Diagnostic Centre's isotope activities 3. HUS Heart and Lung Center's angiography activities 4. Angiography activities in HUS surgeries 5. HUS Cancer Center's radiotherapy and nuclear medicine activities Audits must be carried out in accordance with the Radiation Act and Decree, Decree 1044/2018 of the Ministry of Social Affairs and Health and the recommendations of the expert group on clinical audits of the Ministry of Social Affairs and Health (recommendations 1-19). Audits shall be subject to a written audit report that meets the requirements of regulatory standards. The auditing company shall report in writing every three months on the progress of the audits compared to the audit plan to the project group coordinating the audit of the use of radiation. Branches and geographical area of the activities of the sub-packages: X-ray functions: Diagnostic centre angiography: -Meilahti Tower Hospital (5 angiosalia) -Bridge Hospital (2 halls) -Kymenlaakso Central Hospital (1 angiography room) -South Karelia Central Hospital (1 angiography room) -Meilahti Tower Hospital (1 Hybrid Hall) -Bridge Hospital (3 Hybrid Halls + Raptor Hall) -New Children's Hospital (1 Hybrid Hall + 1 Heart Catheterisation Laboratory Angiosali) -Heart station of Meilahti Tower Hospital (6 angiography halls) -Heart station of Jervi Hospital (3 angiosali) -Heart station of Peijas Hospital (1 angiosali) -Heart station of Hyvinkää Hospital (1 angiosali) HUS Cancer Center: •Safety licence 2517 (radiotherapy) - Cancer Center, Haartmaninkatu 4/Paciuksenkatu 3:13 linear accelerators, 2 post-loading devices, 4 clipping devices for radiotherapy design description,1 BNCT therapy device - In-eye radiotherapy (Tammisairaala and Cancer Center) •Safety licence 145 (radiopharmaceutical activities) - Cancer Center, Haartmaninkatu 4 / Paciuksenkatu 3:2 SPECT-TT devices, Self-manufacturing of radiopharmaceuticals, Policlinical radiopharmaceutical treatments and treatments in ward S4A (Bridge Hospital) The estimated starting date of the contract period is 5.4.2027.The purpose of the request for information is to gather information on the implementation model and operating environment. The information will be used in the preparation of the call for tenders. This is not a contract notice and is not binding on the contracting entity. Information to be requested from the service providers Service package The client has planned the division of the audit package into sub-packages 1-5, as described above. - Do you think that the proposed subdivision into sub-assemblies works or would you suggest another model, e.g. isotope/ X-ray/radiotherapy subdivision? We ask suppliers interested in the procurement to tell us about the solutions you offer, taking into account the above-mentioned background and objectives of the procurement. Please send your responses to the request for information by 18 August 2026 to the address myyntitus.palvelut@hus.fi. The subject of the message is "Request for information External clinical audits of the use of radiation [Company name] [dd.mm.yyyy]". This request for information is not a contract notice and does not constitute a commitment to purchase. The information obtained will be used in the preparation of the tendering process. The responses to this request for information may be used in the planning of the procurement. Suppliers who have responded to a request for information may receive preliminary tender documentation for comments. A contracting entity does not launch a call for tenders with the publication of a request for information, but a possible contract notice and a call for tenders will be published later. The request for information does not oblige the contracting entity to carry out the actual procurement. Responding to a request for information is not a condition for participation in any subsequent invitation to tender.
79000000 - Business services: law, marketing, consulting, recruitment, printing and security
85000000 - Health and social work services
33000000 - Medical equipments, pharmaceuticals and personal care products
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.